First Light Diagnostics
First Light Diagnostics: Innovating rapid, accurate diagnostic tests for life-threatening pathogens.
Founded
2006First Light Diagnostics: Innovating rapid, accurate diagnostic tests for life-threatening pathogens.
Founded with a mission to revolutionize the diagnostic testing landscape, First Light Diagnostics focuses on developing innovative tests for the rapid and accurate detection of life-threatening pathogens. The company's flagship product, the MultiPath benchtop analyzer, offers culture-free results, significantly reducing the time required for pathogen identification and antimicrobial susceptibility testing from days to mere hours. This technology aims to enhance patient outcomes and streamline clinical workflows, targeting healthcare providers and laboratories in urgent need of faster diagnostic solutions.
Key figures associated with First Light Diagnostics include experts in microbiology and medical diagnostics, though specific names are not provided. The company has attracted significant interest from investors in the healthcare and biotech sectors, recognizing its potential to transform diagnostic practices. Notable achievements include the development and successful deployment of the MultiPath technology, which has set a new standard in rapid diagnostics. Overall, First Light Diagnostics is making a substantial impact by enabling quicker, more effective treatment decisions and improving patient care on a global scale.
Companies similar to First Light Diagnostics include Instadiagnostics, Specific Diagnostics, Prompt Diagnostics and Accelerate Diagnostics.
First Light Diagnostics was founded in 2006.
First Light Diagnostics' headquarters is located in Chelmsford, MA, US.
First Light Diagnostics' most recent funding round was for $4M (USD) in October 2020.
As of Oct 27, 2020, First Light Diagnostics has raised a total of $37.5M (USD).
First Light Diagnostics has 36 employees as of Feb 4, 2024.
Prompt Diagnostics
prompt-dx.com
